Literature DB >> 21849796

Histological diagnosis determines complications of percutaneous renal biopsy: a single-center experience in 353 patients.

Viktória Fisi1, István Mazák, Péter Degrell, Richárd Halmai, Gergo A Molnár, Eszter Fehér, Kinga Németh, István Pintér, Tibor Kovács, István Wittmann.   

Abstract

BACKGROUND: We studied the connection between complication occurrence related to renal biopsies and histological diagnoses of the biopsy specimen. We also analyzed the distribution of diagnoses in our population.
METHODS: We retrospectively studied 353 patients undergoing renal biopsy at the same center. Biopsies were performed after marking the site of puncture by ultrasound imaging. Connection of complications with diagnoses and clinical parameters was evaluated.
RESULTS: Complication rate was 44.5% in our study. There was a significantly lower rate of complications in patients with diabetic nephropathy (likelihood ratio, LR = 0.44) or acute tubular necrosis (LR = 0.38), while patients with thin basement membrane syndrome had a more than 6-fold higher risk for development of intrarenal hemorrhage than others. Patients with vasculitis (LR = 2.88) and acute interstitial nephritis (LR = 3.18) have a more than doubled risk for arteriovenous shunts, while in patients with severe arteriosclerosis the prevalence of this complication was lower (LR = 0.46). Arteriovenous shunts developed also at a significantly higher rate in patients with rapidly progressive glomerulonephritis.
CONCLUSION: Patients with thin basement membrane syndrome, vasculitis, rapidly progressive glomerulonephritis or acute interstitial nephritis should be observed more carefully after renal biopsy due to the significantly higher risk for certain complications.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2011        PMID: 21849796     DOI: 10.1159/000329939

Source DB:  PubMed          Journal:  Kidney Blood Press Res        ISSN: 1420-4096            Impact factor:   2.687


  8 in total

Review 1.  Complications of Percutaneous Renal Biopsy.

Authors:  Kenaz Bakdash; Kristofer M Schramm; Aparna Annam; Matthew Brown; Kimi Kondo; Jonathan D Lindquist
Journal:  Semin Intervent Radiol       Date:  2019-05-22       Impact factor: 1.513

2.  A novel differential diagnostic model based on multiple biological parameters for immunoglobulin A nephropathy.

Authors:  Jing Gao; Yong Wang; Zhennan Dong; Zhangming Yan; Xingwang Jia; Yaping Tian
Journal:  BMC Med Inform Decis Mak       Date:  2012-06-27       Impact factor: 2.796

Review 3.  New developments in the genetics, pathogenesis, and therapy of IgA nephropathy.

Authors:  Riccardo Magistroni; Vivette D D'Agati; Gerald B Appel; Krzysztof Kiryluk
Journal:  Kidney Int       Date:  2015-09-16       Impact factor: 10.612

Review 4.  Factors that can minimize bleeding complications after renal biopsy.

Authors:  M S Zhu; J Z Chen; A P Xu
Journal:  Int Urol Nephrol       Date:  2014-08-24       Impact factor: 2.370

5.  Detection of water-molecular-motion configuration in patients with lupus nephritis: a primary study using diffusion-weighted imaging.

Authors:  Huilan Shi; Yanyan Wang; Tiekun Yan; Junya Jia; Dong Li; Li Wei; Wenya Shang; Zhenfeng Zheng
Journal:  BMC Nephrol       Date:  2020-07-29       Impact factor: 2.388

6.  Blood oxygen level-dependent magnetic resonance imaging for detecting pathological patterns in patients with lupus nephritis: a preliminary study using gray-level co-occurrence matrix analysis.

Authors:  Huilan Shi; Junya Jia; Dong Li; Li Wei; Wenya Shang; Zhenfeng Zheng
Journal:  J Int Med Res       Date:  2017-08-08       Impact factor: 1.671

7.  A diagnostic model for minimal change disease based on biological parameters.

Authors:  Hanyu Zhu; Qiuxia Han; Dong Zhang; Yong Wang; Jing Gao; Wenjia Geng; Xiaoli Yang; Xiangmei Chen
Journal:  PeerJ       Date:  2018-01-12       Impact factor: 2.984

8.  Establishment of a novel nomogram for the clinically diagnostic prediction of minimal change disease, -a common cause of nephrotic syndrome.

Authors:  Gaofei Yan; Guanzhi Liu; Xuefei Tian; Lifang Tian; Hao Wang; Peiyao Ren; Xiaotao Ma; Rongguo Fu; Zhao Chen
Journal:  BMC Nephrol       Date:  2020-09-14       Impact factor: 2.388

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.